GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1551 - 1575** of **4050** in total

« First

‹ Prev

…

59

60

61

62

63

64

65

66

67

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgM	Patient 3	11	mild	G27689OB	119
IgM	Patient 3	4	mild	G10789DJ	119
IgG	Patient 4	12	mild	G00048MO	119
IgG	Patient 2	15	mild	G92022ML	120
IgG	Patient 2	24	mild	G51175PR	120
IgG	Patient 2	24	mild	G61399NC	120
IgM	Patient 2	3	mild	G49916XD	120
IgM	Patient 3	-180	mild	G91537AT	120
IgG	Patient 3	4	mild	G14988WV	120
IgM	Patient 3	11	mild	G00051MO	120
IgG	Patient 4	12	mild	G00066MO	120
IgM	Patient 2	15	mild	G98068PA	121
IgG	Patient 3	-180	mild	G65889KE	121
IgM	Patient 3	4	mild	G65889KE	121
IgM	Patient 3	4	mild	G93351GM	121
IgG	Patient 1	6	moderate	G17689EW	122
IgM	Patient 1	22	moderate	G19868AX	122
IgM	Patient 1	22	moderate	G90562PB	122
IgG	Patient 2	24	mild	G71142DF	122
IgG	Patient 2	3	mild	G22768VO	122
IgM	Patient 3	-180	mild	G51872EK	122
IgM	Patient 3	11	mild	G28868ZC	122
IgM	Patient 3	11	mild	G61399NC	122
IgM	Patient 3	4	mild	G47548GA	122
IgG	Patient 4	12	mild	G39023AU	122